Godavari Biorefineries Secures US Patent for Novel Cancer Treatment Compounds
Godavari Biorefineries Ltd 路 Others (Uncategorized) 路 14 Oct 2026, 11:32 pm
Godavari Biorefineries Secures US Patent for Novel Cancer Treatment Compounds Godavari Biorefineries Limited has been granted a US patent for "5-HYDROXY-1,4-NAPHTHALENEDIONE FOR USE IN THE TREATMENT OF CANCER," as disclosed on 14th Oct'26. The patent protects a novel class of compounds engineered to inhibit cancer and cancer stem cells, demonstrating strong therapeutic potential across multiple indications, including breast and prostate cancers. The approval strengthens the company's proprietary oncology pipeline and global intellectual property portfolio.
Original exchange filing (PDF)
More announcements from Godavari Biorefineries Ltd
- Transcript of earnings call of Q2 and H1 of FY 27 held on 6th November, 2026 路 13 Nov 2026
- Audio Recording of Earnings Call of Q2 and H1 of FY 27 financail results 路 06 Nov 2026
- Investor Presentation for Q2 and H1 of FY 27 路 06 Nov 2026
- Press release for the quarter and half year ended 30th September, 2026 路 05 Nov 2026
- Unaudited Financial Results for the Quarter and Half Year ended 30th September, 2026 路 05 Nov 2026
- Godavari Biorefineries Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 05 Nov 2026
- Unaudited Financial Results for the Quarter and Half Year ended 30th September, 2026 路 05 Nov 2026
- GODAVARI BIOREFINERIES LIMITED has informed the Exchange about Board Meeting to be held on 04-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . 路 04 Nov 2026
